卡尔-NK细胞疗法:在固体瘤中的承诺和挑战
Sahar Balkhi1, Gaia Zuccolotto2, Anna Di Spirito1
1Immunology and General Pathology Laboratory, Department of Biotechnology and Life Sciences, University of Insubria, Varese, Italy.
Frontiers in immunology
|April 22, 2025
概括
自然杀手 (NK) 细胞疗法是一种细胞免疫疗法,在治疗癌症方面表现有前途. 下一代CAR-NK疗法正在开发中,以提高疗效,并将其用于固体瘤.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 生物技术是生物技术.
背景情况:
- 化学抗原受体T细胞 (CAR-T) 疗法是已确立的血液癌症治疗方法.
- 对CAR-T疗法的挑战包括自身产品的制造和毒性管理.
- 自然杀手 (NK) 细胞为通用,现成的细胞疗法提供了潜力.
研究的目的:
- 审查当前的趋势和新兴的概念在工程下一代CAR-NK疗法.
- 讨论CAR-NK细胞在固体瘤中的应用.
- 检查CAR-NK疗法的优势,局限性和未来的挑战.
主要方法:
- 关于CAR-NK细胞疗法的当前文献的综述.
- 讨论CAR-NK细胞结构和目标识别.
- 分析CAR-NK的作用机制和实体瘤的研究现状.
主要成果:
- 对CD19-CAR-NK细胞的首次人体试验表明,在淋巴细胞恶性瘤中具有安全性和临床活性.
- 目前正在进行研究,以增强CAR-NK细胞的持久性和对抗功能疲.
- 越来越多的人对将CAR-NK疗法应用于固体瘤感兴趣.
结论:
- CAR-NK细胞为下一代细胞免疫疗法提供了一个有前途的途径.
- 需要进一步的研究,以优化CAR-NK疗法用于更广泛的应用,包括固体瘤.
- 工程CAR-NK细胞具有改善癌症治疗策略的潜力.
相关概念视频
Tumor Immunotherapy
398
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
398
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Cytotoxic T Cells-mediated Immune Response
725
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
725


